For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.
Sandra L. Tunis, PhD
Advertisement
Articles by Sandra L. Tunis, PhD
Advertisement
Latest Updated Articles
- Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States
Published: March 1st 2008 | Updated:
- The Impact of Schizophrenic Patient Functionality on Service Utilization and Cost
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
2
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5
